The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Specific control for intracellular staining of human IL-12 p70-producing cells. Pharmingen's HiCK-3 positive control cells (Cat. No. 555063) were intracellulary stained using Pharmingen's intracellular staining protocol. The panels show intracellular staining with PE-conjugated antihuman IL-12 p70 (0.06 µg) and the pre-blocking of that staining with purified anti-human IL-12 p70 (5.0 µg, see right panel).
Specific control for intracellular staining of human IL-12 p70-producing cells. Pharmingen's HiCK-3 positive control cells (Cat. No. 555063) were intracellulary stained using Pharmingen's intracellular staining protocol. The panels show intracellular staining with PE-conjugated antihuman IL-12 p70 (0.06 µg) and the pre-blocking of that staining with purified anti-human IL-12 p70 (5.0 µg, see right panel).
Specific control for intracellular staining of human IL-12 p70-producing cells. Pharmingen's HiCK-3 positive control cells (Cat. No. 555063) were intracellulary stained using Pharmingen's intracellular staining protocol. The panels show intracellular staining with PE-conjugated antihuman IL-12 p70 (0.06 µg) and the pre-blocking of that staining with purified anti-human IL-12 p70 (5.0 µg, see right panel).
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Immunofluorescent Staining and Flow Cytometric Analysis: The 20C2 antibody is useful for immunofluorescent staining and flow cytometric analysis of mixed cell populations to identify and enumerate IL-12 p70 producing cells. This 100 Test Size formulation of the PE-conjugated 20C2 antibody has been pre-titrated to assure effective intracellular detection of human IL-12 p70 using 20 µl/1 x 10^6 cells.
A suitable rat IgG1 isotype control for assessing the level of fluorochrome associate background staining on paraformaldehyde-fixed/saponin-permeabilized human cells is also available in a 100 Test Size formulation PE-R3-34 immunoglobulin (Cat. No. 559318). A useful control for demonstrating specificity of staining is either of the following: 1) pre-block the fluorochrome-conjugated 20C2 antibody with excess ligand (e.g., recombinant human IL-12 p70, Cat. No. 554613) prior to staining, or 2) pre-block the fixed/permeabilized cells with unlabeled 20C2 antibody (Cat. No. 557018) prior to staining. The intracellular staining technique and use of blocking controls are described in detail by C. Prussin and D. Metcalfe.
Important Note: This pre-titered antibody solution does not contain a cell permeabilization agent. It is necessary to include a cell permeabilization agent when using the pre-titered antibody solution to stain fixed and permeabilized cells. Perm/Wash™ Buffer (Cat. No. 554723) contains the permeabilization agent saponin and is useful for this purpose.
The 20C2 antibody reacts with the biologically active form of human IL-12 p70 heterodimer, but not with the p40 monomer or homodimer.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.